Quantitative proteomics reveals a broad‐spectrum antiviral property of ivermectin, benefiting for COVID‐19 treatment
Viruses such as HPV, HIV, coronavirus are great burden to human world. Ivermectin is a FDA approved anti-parasite drug, and it is also used as an antibacterial, antiviral and anticancer agent. It can effectively inhibit the replication of SARS‐CoV‐2 in vitro.